跳至主要内容
临床试验/JPRN-UMIN000040821
JPRN-UMIN000040821已完成未知

The effect of continuous intake of foods containing plant extract on neutral fat, liver fat and uric acid levels. - The effect of continuous intake of foods containing plant extract on neutral fat, liver fat and uric acid levels.

IMEQRD Co., Ltd0 个研究点目标入组 60 人开始时间: 2020年6月26日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 65years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1.Those who are currently receiving any types of medicines and/or Chinese medical treatment (except for the medication needed). 2.Those who have or had a severe disease of the liver, kidney, heart, respiratory, endocrine and metabolic diseases. 3.Those who are treated for the dyslipidemia or hyperuricemia. 4.Those who have undergone gastrointestinal surgery (appendicitis acceptable). 5.Those who have been routinely taking foods for specified health use, health foods with functional claims or supplements, which are expected to improve body fat reduction or lipid metabolism-related test values and uric acid levels. 6.Those who cannot abstain from taking health food other than test food during the test period. 7.Those who have a current or previous history of drug and/or food allergies. 8.Heavy drinkers. 9.Those who have metals implanted in the body due to surgery etc. 10.Those who have a cardiac pacemaker or an implantable medical device placed in the body. 11.Those who have claustrophobia. 12.Those who work night shifts. 13.Those who are currently undergoing treatment for drug dependence or drug abuse or those who have a past medical history of either of htem. 14.Those who have collected or donated more than 200mL within 1 month or 400mL within 3 months of the pre-examination. 15.Those who are surrently pregnant or breastfeeding or those who want to become pregnant during the study period. 16.Those who are currently participating in another clinical trial or those who took a test product and completed another clinical trial in a month. 17.Those who were determined by the principal investigator and the sub investigator to be unsuitable for participation in this clinical trial.

研究者

发起方
IMEQRD Co., Ltd

相似试验